PD-1/PD-L1 immune-checkpoint inhibitors in glioblastoma: A concise review

Critical Reviews in Oncology/hematology
Mario CacceseGiuseppe Lombardi

Abstract

Glioblastoma is the most aggressive and most common primary brain tumor in adults, with a very poor prognosis, due to limited therapeutic efficacy of available treatments. The promising data deriving from the use of immune checkpoint inhibitors (ICI) in other cancers have prompted evaluation of its efficacy and possible use in patients with glioblastoma. In this review, we analyzed the available data about these drugs in glioblastoma. Although data are not yet mature and preliminary studies do not show a clear-cut benefit, we are far from excluding the concrete possibility of using ICI as potential treatment in patients with glioblastoma. Moreover, many molecular and immunological aspects of this approach have yet to be clarified. For this reason, it is essential to identify potential predictive biomarkers for the selection of patients who will benefit most from treatment with ICI. Additional effort is needed to better understand the mechanisms that will allow us to establish whether ICI have a place in the treatment of patients with glioblastoma.

Citations

Jul 14, 2019·Journal of Cellular Physiology·Shaochen FanYilu Gao
Apr 19, 2020·Journal for Immunotherapy of Cancer·Matheus H W CrommentuijnYvette van Kooyk
Apr 18, 2020·Expert Review of Anticancer Therapy·Michael RuffJan Buckner
May 24, 2020·Medicinal Research Reviews·Ge YanZhiqiang Li
Jul 10, 2020·Human Vaccines & Immunotherapeutics·Tianrui YangWenbin Ma
Aug 3, 2019·Medicines·Purushottam LamichhaneNarottam Lamichhane
Aug 9, 2020·Frontiers in Immunology·Syreeta DeCordovaUday Kishore
Feb 6, 2020·International Journal of Clinical Oncology·Yukihiko Sonoda
Jan 25, 2021·Advanced Drug Delivery Reviews·Taskeen Iqbal JanjuaAmirali Popat
Dec 5, 2020·Scientific Reports·Anthony PatrizzYoshua Esquenazi
Dec 19, 2020·Cancers·Giuseppe LombardiPim French
Feb 14, 2021·International Immunopharmacology·Abolfazl MaghrouniAmirhossein Sahebkar
Mar 7, 2021·Brain Sciences·Jakub LitakCezary Grochowski
Mar 7, 2021·Cancers·Hong-My NguyenDipongkor Saha
Mar 26, 2021·Acta Neuropathologica Communications·Yona KimSun Ha Paek
Apr 21, 2021·Neuroscience Bulletin·Junli ZhaoRu-Rong Ji
Jun 3, 2021·Cancers·Mayra PaolilloSergio Schinelli
Jul 16, 2020·Current Drug Metabolism·Elmira MohtashamiAmir R Afshari
Jun 27, 2021·Molecular Cancer Therapeutics·Zilai WangLijun Rong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.